NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

iStock photo of preemie
Durham's Tellus Therapeutics has received Orphan Drug and Rare Pediatric Drug designations from the FDA for its neonatal brain injury treatment.
Emergo logo
Durham's Emergo has just received $3.5 million in equity backing from 77 investors for a new clinical study to see how the therapy works on patients with flu-like symptoms.
LabCorp blood vials
Burlington-based LabCorp has launched a new antibody test for research labs, the latest in a string of contributions to the fight against SARS-CoV-2, the virus that causes COVID-19.
MED-EL illustration of implant
MED-EL Medical Electronics, a hearing-technology company with U.S. headquarters in Durham, was recently named “Innovator of the Year” by the online publication Hearing Health & Technology Matters.
Dorith Rotenberg, NCSU
Scientists now have a complete genetic blueprint to help them better understand the western flower thrips and to find ways to control the pest.
NC Dept of Commerce logo
Any STEM company in North Carolina that has received a specified type of federal grant for research and development has until Dec. 1 to apply for matching state funds through the One NC Small Business Program.
Amanda Taylor
Amanda Taylor, a 29-year veteran of Merck, assumed responsibility for the Maurice R. Hilleman Center for Vaccine Manufacturing in Durham.on August 1.
Merck's Hilleman Center in Durham
The Maurice R. Hilleman Center for Vaccine Manufacturing in Durham, where yet another 100-job expansion was announced this week, is key to Merck’s future as one of the world’s powerhouse vaccine manufacturers.
Polarean logo
Polarean, a Duke University spinout bootstrapped by an NCBiotech loan, has filed a new drug application with the FDA for its unique technology for lung imaging.
Shattuck Labs logo
Shattuck Labs is changing the face of cancer therapy, aided by a $202 million IPO and equity funding that will push its clinical research on cancer immunotherapy to the next level.
Grifols production
Grifols, a global biotherapeutics company, has begun Phase 3 clinical trials in patients with COVID-19 with its therapeutic manufactured in Clayton.
Propella logo
Development-stage pharmaceutical start-up Propella Therapeutics Inc. has just received a patent for its metastatic prostate cancer treatment, PRL-02.
EternaTear logo
EternaTear, young Raleigh startup developing a non-prescription eyedrop to treat dry eye syndrome, says it has raised $4.9 million in an oversubscribed Series A round of funding.
LabCorp logo
Burlington-based LabCorp has received Emergency Use Authorization from the U.S. Food and Drug Administration to deploy an improved laboratory test for detecting the coronavirus infection.

BioAesthetics logo

October is Breast Cancer Awareness Month, and a Research Triangle Park company developing a unique breast reconstruction option for mastectomy patients is raising awareness with its investment support.